| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468085A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468014A2 Compositions and methods for wt1 specific immunotherapy |
| 10/20/2004 | EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467981A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467967A1 Compounds for modulating cell proliferation |
| 10/20/2004 | EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467760A2 Systems and methods for photodynamic therapy |
| 10/20/2004 | EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 10/20/2004 | EP1467758A2 Methods for preparing immunoconjugates |
| 10/20/2004 | EP1467757A2 Use of antibodies against the muc18 antigen |
| 10/20/2004 | EP1467756A2 Methods for using anti-muc18 antibodies |
| 10/20/2004 | EP1467751A2 Immunogenic cea |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467738A1 Use of prostaglandin e synthase inhibitors, or ep2 or ep4 receptor antagonists, in the treatment of a pathological condition of the uterus |
| 10/20/2004 | EP1467736A2 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| 10/20/2004 | EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467706A2 Dermal application system for aminolevulinic acid-derivatives |
| 10/20/2004 | EP1368327B1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 10/20/2004 | EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 10/20/2004 | EP1171141B1 MEDICAMENT FOR INHIBITING THE NF-kB TRANSCRIPTION FACTOR |
| 10/20/2004 | EP1117416B1 Plant extracts for the treatment of increased bone resorption |
| 10/20/2004 | EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 10/20/2004 | EP0971701B1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 10/20/2004 | EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 10/20/2004 | EP0850062B1 Use of halofuginone for the preparation of a medicament for attenuating neovascularization and for treating human malignant tumours |
| 10/20/2004 | EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
| 10/20/2004 | CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538967A Heterocyclic compound and antitumour agent containing the same as active ingredient |
| 10/20/2004 | CN1538964A Substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538952A Protected 3,5-dihydroxy-2, 2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for production and use thereof |
| 10/20/2004 | CN1538854A Mutant forms of cholera holotoxin as adjuvant |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538847A 4-amino-6-phenyl-pyrrolo [2,3-D] pyrimidine derivatives |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use |
| 10/20/2004 | CN1538842A Atineoplastic combinations |
| 10/20/2004 | CN1538841A C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537866A Heteroprotein of melanoma epi (Mage-1, HLA-Al) and bacteriophage coat protein and its application |
| 10/20/2004 | CN1537637A Nucleic acid vaccine |
| 10/20/2004 | CN1537633A Protein having antitumor function, and high performance expression in vitro |
| 10/20/2004 | CN1537626A Pill for treating lung disease, and its prepn. method |
| 10/20/2004 | CN1537621A External-applied type traditional Chinese medicine for treating liver cancer, and its prepn. method |
| 10/20/2004 | CN1537619A Traditional Chinese medicine for immunity and strengthening the body resistance |
| 10/20/2004 | CN1537602A Traditional Chinese medicine pill for taking care of heart, brain and kidney |
| 10/20/2004 | CN1537569A External-used drug for treating liver cancer, and its prepn. art |
| 10/20/2004 | CN1537568A Oral medicine for treating liver cancer |
| 10/20/2004 | CN1537566A Pure herb medicine prepn. contg. acer truncatum and others, and its prepn. method |
| 10/20/2004 | CN1537565A Traditonal chinese softgel for treating cancer contg. acer truncatum and other three herbs, and its preparing process |
| 10/20/2004 | CN1537564A Traditional chinese medicine prepns. for treating broad-spectrum cancers |
| 10/20/2004 | CN1537535A Freezing-dried composite contg. dexrazoxane and its prepn. method |
| 10/20/2004 | CN1537534A Liposome of 10-hydroxycamptothecine, and its prepn. method |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1537530A Unit dosage type compound cantharis acid powder-injection, and its prepn. method |
| 10/20/2004 | CN1537519A Golden eye shade cover, and its making method |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171895C Chiral octahedral Mo-W complexes, their synthesis method and application for preparing anticancer medicine |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 10/20/2004 | CN1171870C Inhibitors of cysteine protease |
| 10/20/2004 | CN1171866C Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 10/20/2004 | CN1171851C Diterpene compound and its prepn and use |
| 10/20/2004 | CN1171850C Diterpene compound and its prepn and use |
| 10/20/2004 | CN1171640C Preparation method of liver cancer superantigen immunogene therapy agent |
| 10/20/2004 | CN1171631C Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 10/20/2004 | CN1171630C LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same |
| 10/20/2004 | CN1171593C Embedded musk and its preparing process |
| 10/19/2004 | US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 10/19/2004 | US6806312 Thermoplastic resin composition |
| 10/19/2004 | US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 10/19/2004 | US6806266 Staurosporin derivatives |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6806255 Compounds and methods for modulating adhesion molecule function |